Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,855 | -3,857 | -3,169 | -1,856 | -1,072 |
| Depreciation Amortization | 3 | 11 | 8 | 5 | 3 |
| Other Working Capital | 92 | -40 | -50 | -258 | -149 |
| Other Operating Activity | 1,675 | -849 | -238 | -255 | -48 |
| Operating Cash Flow | $-2,085 | $-4,735 | $-3,449 | $-2,364 | $-1,265 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -529 | -4 | -117 | 83 |
| Other Investing Activity | 0 | -14 | -14 | -14 | -14 |
| Investing Cash Flow | $N/A | $-542 | $-18 | $-131 | $70 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,250 | N/A | N/A | N/A |
| Common Stock Issued | 7,429 | 415 | 415 | 415 | 415 |
| Other Financing Activity | -12 | -43 | -31 | -21 | -10 |
| Financing Cash Flow | $7,417 | $2,623 | $384 | $395 | $405 |
| Exchange Rate Effect | 3 | 3 | 4 | -1 | -2 |
| Beginning Cash Position | 3,923 | 6,574 | 6,574 | 6,574 | 6,574 |
| End Cash Position | 9,258 | 3,923 | 3,495 | 4,473 | 5,781 |
| Net Cash Flow | $5,335 | $-2,651 | $-3,079 | $-2,101 | $-793 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,085 | -4,735 | -3,449 | -2,364 | -1,265 |
| Free Cash Flow | -2,085 | -4,735 | -3,449 | -2,364 | -1,265 |